Omnicell soars after bullish quarterly report, outlook

Omnicell

30/10/2024 17:08

** Shares in Omnicell Inc  OMCL.O  surging 33.9% on Wednesday,
on track for record one-day pct gain after it reported Q3 EPS
that soundly beat Wall St estimates and it increased its full
year financial targets
    ** The provider of medication management, adherence tools
for health systems and pharmacies reported adj EPS of $0.56 vs
Wall St consensus expectation of $0.40 and reported rev of
$282.42 mln vs avg est of $280.45 mln, as per LSEG
    ** OMCL forecast FY 2024 non-GAAP EPS between $1.65 and
$1.72 vs previous target range announced on Aug 1 for FY EPS
between $1.20 and $1.50 per share, while it sees total rev
between $1.10 bln and $1.11 bln, up from previous target range
of between $1.07 bln and $1.11 bln 
    ** OMCL last traded at $53.64 vs median PT of $44.50,
according to LSEG, which shows 9 analyst ratings: 1 'strong
buy,; 3 'buy' and 5 'hold' ratings
    ** YTD the stock is up 42% vs gain of 8% for S&P 1500 health
care sector index  .SPCOMA   

 (Reporting By Sinéad Carew)
 ((sinead.carew@thomsonreuters.com; +13322191897;))